Pfizer, the world’s largest pharmaceutical company, recently opened a global drug research and development centre in Chennai’s IIT-Madras Research Park with an initial investment of around ?150 crore. The 61,000-square-foot research and technology centre will be part of a global network of 12 centres, and it’ll be Pfizer’s first and only one in Asia.
*Image used if any in this post is for illustration only
Note: The above-mentioned project news is taken from ProjectX India | 15th May 2022 edition. Click here to buy this issue. Access Drugs/Pharma news, projects, tenders, and contract award information in each fortnightly issue of ProjectX India PDF version. Go for an annual subscription and get access to 24 issues in a year.